OTCMKTS:PCHM PharmChem (PCHM) Stock Price, News & Analysis $3.50 -0.05 (-1.41%) As of 05/22/2025 12:30 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsShort InterestBuy This Stock About PharmChem Stock (OTCMKTS:PCHM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PharmChem alerts:Sign Up Key Stats Today's Range$3.50▼$3.5050-Day Range$2.97▼$3.5552-Week Range$2.85▼$4.00Volume1,999 shsAverage Volume6,527 shsMarket Capitalization$16.27 millionP/E Ratio12.07Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.Read More… Receive PCHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmChem and its competitors with MarketBeat's FREE daily newsletter. Email Address PCHM Stock News HeadlinesPharmChem, Inc. (PCHM) Latest Press Releases & Corporate News - Yahoo FinanceApril 29, 2025 | finance.yahoo.comPharmChem (OTC:PCHM) Stock Quotes, Forecast and News SummaryFebruary 9, 2025 | benzinga.comThe Secret to Finding Breakout Stocks (Free eBook Inside!)What if you could eliminate all the uncertainty from your trading? This isn’t just a theory—it’s a game-changer. What if, in just seconds, you could pinpoint trending small cap companies? With a single alert, you’d know exactly when to move— Here’s the good news: our team specializes in uncovering hidden gems before the market catches on.May 23, 2025 | Krypton Street (Ad)PharmChem considers strategic alternativesFebruary 3, 2025 | msn.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | gurufocus.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | prnewswire.comCedar Creek Partners Q3 2024 ResultsOctober 24, 2024 | seekingalpha.comPharmChem, Inc. goes ex dividend tomorrowOctober 9, 2024 | msn.comSee More Headlines PCHM Stock Analysis - Frequently Asked Questions How have PCHM shares performed this year? PharmChem's stock was trading at $3.06 on January 1st, 2025. Since then, PCHM shares have increased by 14.4% and is now trading at $3.50. View the best growth stocks for 2025 here. How were PharmChem's earnings last quarter? PharmChem, Inc. (OTCMKTS:PCHM) released its quarterly earnings data on Friday, May, 9th. The company reported $0.06 EPS for the quarter. The firm earned $1.58 million during the quarter. How do I buy shares of PharmChem? Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/09/2025Today5/23/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolOTCMKTS:PCHM CIKN/A Webwww.pharmchek.com Phone(855) 458-4100Fax817-605-6400Employees170Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.32 Trailing P/E Ratio12.07 Forward P/E RatioN/A P/E GrowthN/ANet Income$850,000.00 Net Margins23.32% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.01 million Price / Sales2.71 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,648,000Free Float3,839,000Market Cap$16.27 million OptionableNot Optionable Beta0.73 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (OTCMKTS:PCHM) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmChem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmChem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.